These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10645004

  • 1. Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein.
    Todd MC, Sclafani RA, Langan TA.
    Oncogene; 2000 Jan 13; 19(2):258-64. PubMed ID: 10645004
    [Abstract] [Full Text] [Related]

  • 2. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
    Todd MC, Spruill SC, Meerbrey KL.
    Int J Oncol; 2009 Aug 13; 35(2):375-80. PubMed ID: 19578752
    [Abstract] [Full Text] [Related]

  • 3. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 13; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S, El-Naggar AK.
    Lab Invest; 1999 Mar 13; 79(3):255-60. PubMed ID: 10092061
    [Abstract] [Full Text] [Related]

  • 5. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
    Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C.
    Clin Cancer Res; 1999 Feb 13; 5(2):243-50. PubMed ID: 10037171
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 7. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S, Mihara M, Nakahara Y, Kiyota A, Yoshihama Y, Ueyama Y, Matsumura T.
    Anticancer Res; 2000 Jun 10; 20(3B):2169-75. PubMed ID: 10928172
    [Abstract] [Full Text] [Related]

  • 8. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB, Lantuejoul S, Abbondanzo S, Chu WS, Hasleton PS, Travis WD, Brambilla E.
    Hum Pathol; 2003 Feb 10; 34(2):136-42. PubMed ID: 12612881
    [Abstract] [Full Text] [Related]

  • 9. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A.
    Gynecol Oncol; 2001 Dec 10; 83(3):491-500. PubMed ID: 11733961
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, Sengoku K, Ishikawa M.
    Exp Cell Res; 1997 Jun 15; 233(2):233-9. PubMed ID: 9194486
    [Abstract] [Full Text] [Related]

  • 11. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer].
    Dai S, Huang W, Gan X.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct 15; 32(5):299-301. PubMed ID: 10743098
    [Abstract] [Full Text] [Related]

  • 12. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ.
    J Pathol; 2004 Jul 15; 203(3):762-70. PubMed ID: 15221935
    [Abstract] [Full Text] [Related]

  • 13. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK.
    Gynecol Oncol; 2001 Dec 15; 83(3):543-8. PubMed ID: 11733969
    [Abstract] [Full Text] [Related]

  • 14. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
    Park HW, Song SY, Lee TJ, Jeong D, Lee TY.
    Oncol Rep; 2007 Jul 15; 18(1):267-72. PubMed ID: 17549378
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
    Grim J, D'Amico A, Frizelle S, Zhou J, Kratzke RA, Curiel DT.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2415-23. PubMed ID: 9815642
    [Abstract] [Full Text] [Related]

  • 16. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J, Ingram CD.
    Mod Pathol; 2000 Sep 15; 13(9):945-53. PubMed ID: 11007034
    [Abstract] [Full Text] [Related]

  • 17. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
    Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, Rollins BJ.
    Cancer Res; 1995 Feb 01; 55(3):505-9. PubMed ID: 7834618
    [Abstract] [Full Text] [Related]

  • 18. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer.
    Kusume T, Tsuda H, Kawabata M, Inoue T, Umesaki N, Suzuki T, Yamamoto K.
    Clin Cancer Res; 1999 Dec 01; 5(12):4152-7. PubMed ID: 10632354
    [Abstract] [Full Text] [Related]

  • 19. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B, Arendt S, Muffler S, Steinkraus V, Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P.
    Eur J Cell Biol; 2007 Dec 01; 86(11-12):763-80. PubMed ID: 17198740
    [Abstract] [Full Text] [Related]

  • 20. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.
    Krecicki T, Smigiel R, Fraczek M, Kowalczyk M, Sasiadek MM.
    J Laryngol Otol; 2004 Sep 01; 118(9):676-80. PubMed ID: 15509364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.